ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
펩타이드 치료제 시장 규모는 최근 급성장하고 있습니다. 2025년 492억 1,000만 달러에서 2026년에는 546억 2,000만 달러에 이르고, CAGR 11.0%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 펩타이드 의약품의 조기 도입, 펩타이드 합성 기술의 발전, 만성질환 및 희귀질환의 발생률 증가, 약리학 및 생화학의 발전, 계약연구기관(CRO)의 성장에 기인한다고 볼 수 있습니다.
펩타이드 치료제 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 835억 7,000만 달러에 이르고, CAGR은 11.2%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 개인 맞춤형 의료의 부상, 펩타이드 기반 치료제에 대한 투자 증가, 신약 개발에 AI의 통합, 바이오 의약품 제조의 확대, 헬스케어 솔루션의 신흥 시장 성장 등을 꼽았습니다. 예측 기간의 주요 동향으로는 표적 펩타이드 의약품 개발, 펩타이드 약물 전달 기술 혁신, 다기능 펩타이드 치료제, 천연 펩타이드 추출 및 합성, 펩타이드를 이용한 병용요법 등을 들 수 있습니다.
만성질환의 유병률 증가는 펩타이드 치료제 시장의 성장을 견인할 것으로 예측됩니다. 만성질환은 완전한 치유는 어렵지만 적절한 치료를 통해 관리할 수 있는 장기적인 병태를 말합니다. 흡연, 영양 부족, 운동 부족, 과도한 음주 등의 요인이 만성질환 증가에 기여하고 있습니다. 펩타이드 치료제는 특정 만성 질환의 예방과 치료에 중요한 역할을 합니다. 예를 들어, 미국 국립의학도서관(National Library of Medicine)의 2023년 1월 추정에 따르면, 2050년까지 미국에서 50세 이상 만성질환을 앓고 있는 사람의 수는 99.5% 증가하여 1억 4,266만 명에 달할 것으로 예측됩니다. 따라서 만성 질환의 유병률 증가는 예측 기간 동안 펩타이드 치료제 시장을 견인할 것으로 예측됩니다.
펩타이드 치료제 시장의 주요 기업들은 경쟁 우위를 확보하기 위해 세포 배양 공정과 같은 첨단 솔루션에 집중하고 있습니다. 세포배양 공정은 세포를 자연환경으로부터 분리하여 통제된 조건에서 배양하고, 원하는 세포를 분리, 유지하여 다양한 용도에 응용하는 기술입니다. 예를 들어, 2023년 6월 독일에 본사를 둔 특수 화학 기업 에보닉 인더스트리즈(Evonik Industries AG)는 세포 배양 공정에서 바이오 의약품 용도로 설계된 차세대 펩타이드 'cQrex KC'를 발표하였습니다. cQrex KC는 시스틴 공급을 최적화하고, 세포배양 생산성을 향상시켜 백신, 바이러스 벡터, 세포치료제 개발을 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Peptide therapeutics refer to a treatment approach that uses peptides as medications. Peptides are a unique class of pharmacological agents that fall between proteins and small molecules in size. Naturally occurring peptides serve multiple functions, including acting as hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives. Using peptides as therapeutics provides a way to target specific cells and modulate their responses.
The main types of peptide therapeutics are generic and branded. Branded peptide therapeutics are marketed under the brand names of major pharmaceutical companies that hold the patents, making them more expensive than generic alternatives. These therapeutics can be administered via parenteral, mucosal, oral, and transdermal routes. They are used in the treatment of cancer, cardiovascular diseases, central nervous system disorders, metabolic disorders, infections, hematological conditions, gastrointestinal disorders, dermatological conditions, respiratory disorders, and acromegaly.
Tariffs have influenced the peptide therapeutics market by increasing import costs for raw materials and active pharmaceutical ingredients, particularly affecting peptide synthesis and delivery technology segments. Regions such as North America and Europe, which rely on imports from Asia-Pacific manufacturing hubs like China and India, are most impacted. While tariffs raise production costs and slow market expansion, they also incentivize local production, innovation in cost-effective peptide manufacturing, and development of domestic supply chains, providing potential long-term benefits.
The peptide therapeutics market research report is one of a series of new reports from The Business Research Company that provides peptide therapeutics market statistics, including peptide therapeutics industry global market size, regional shares, competitors with a peptide therapeutics market share, detailed peptide therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the peptide therapeutics industry. This peptide therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The peptide therapeutics market size has grown rapidly in recent years. It will grow from $49.21 billion in 2025 to $54.62 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to early adoption of peptide drugs, development of peptide synthesis techniques, increasing incidence of chronic and rare diseases, advances in pharmacology and biochemistry, growth of contract research organizations.
The peptide therapeutics market size is expected to see rapid growth in the next few years. It will grow to $83.57 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to rise of personalized medicine, increasing investment in peptide-based therapeutics, integration of AI in drug discovery, expansion of biologics manufacturing, growth in emerging markets for healthcare solutions. Major trends in the forecast period include targeted peptide drug development, peptide drug delivery innovations, multi-functional peptide therapeutics, natural peptide extraction & synthesis, combination therapies with peptides.
The rising prevalence of chronic diseases is expected to drive growth in the peptide therapeutics market. Chronic diseases are long-lasting medical conditions that may not be fully curable but are often manageable with appropriate treatment. Factors such as tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption contribute to the increasing incidence of chronic diseases. Peptide therapeutics play a key role in the prevention and treatment of certain chronic conditions. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of individuals in the U.S. aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050. Therefore, the growing prevalence of chronic diseases is expected to propel the peptide therapeutics market during the forecast period.
Major companies in the peptide therapeutics market are focusing on advanced solutions such as cell culture processes to gain a competitive advantage. Cell culture processes involve growing cells outside their natural environment under controlled conditions, isolating cells of interest, and maintaining them for various applications. For instance, in June 2023, Evonik Industries AG, a Germany-based specialty chemicals company, launched cQrex KC, a next-generation peptide designed for biopharmaceutical applications in cell culture processes. cQrex KC helps optimize cystine supply, enhance cell culture productivity, and supports the development of vaccines, viral vectors, and cell therapies.
In July 2024, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, acquired Amolyt Pharma for $1.05 billion. This acquisition strengthens AstraZeneca's capabilities in rare diseases and expands its therapeutic offerings in high-need areas. Amolyt Pharma, a France-based clinical-stage biotechnology company, specializes in developing therapeutic peptides for the treatment of rare endocrine and metabolic disorders.
Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the peptide therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The peptide therapeutics market includes revenues earned by entities by creating drugs to treat a variety of diseases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Peptide Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses peptide therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for peptide therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peptide therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Generic; Branded
2) By Route of Administration: Parenteral; Mucosal; Oral; Transdermal
3) By Application: Cancer; Cardiovascular Diseases; Central Nervous Systems; Metabolic Disorders; Infections; Hematological Disorders; Gastrointestinal Disorders; Dermatology; Respiratory Disorders; Acromegaly; Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs; Biosimilars
2) By Branded: Innovative Peptide Drugs; Patent-Protected Peptides
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Targeted Peptide Drug Development
4.2.2 Peptide Drug Delivery Innovations
4.2.3 Multi-Functional Peptide Therapeutics
4.2.4 Natural Peptide Extraction & Synthesis
4.2.5 Combination Therapies With Peptides
5. Peptide Therapeutics Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialty Clinics
5.3 Research Laboratories
5.4 Pharmaceutical Companies
5.5 Biotechnology Firms
6. Peptide Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Peptide Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Peptide Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Peptide Therapeutics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Peptide Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Peptide Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Peptide Therapeutics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Peptide Therapeutics Market Segmentation
9.1. Global Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Generic, Branded
9.2. Global Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Parenteral, Mucosal, Oral, Transdermal
9.3. Global Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
9.4. Global Peptide Therapeutics Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Generic Peptide Drugs, Biosimilars
9.5. Global Peptide Therapeutics Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Peptide Therapeutics Market
12.1. China Peptide Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Peptide Therapeutics Market
13.1. India Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Peptide Therapeutics Market
14.1. Japan Peptide Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Peptide Therapeutics Market
15.1. Australia Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Peptide Therapeutics Market
16.1. Indonesia Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Peptide Therapeutics Market
17.1. South Korea Peptide Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Peptide Therapeutics Market
18.1. Taiwan Peptide Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Peptide Therapeutics Market
19.1. South East Asia Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Peptide Therapeutics Market
20.1. Western Europe Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Peptide Therapeutics Market
21.1. UK Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Peptide Therapeutics Market
22.1. Germany Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Peptide Therapeutics Market
23.1. France Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Peptide Therapeutics Market
24.1. Italy Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Peptide Therapeutics Market
25.1. Spain Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Peptide Therapeutics Market
26.1. Eastern Europe Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Peptide Therapeutics Market
27.1. Russia Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Peptide Therapeutics Market
28.1. North America Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Peptide Therapeutics Market
29.1. USA Peptide Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Peptide Therapeutics Market
30.1. Canada Peptide Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Peptide Therapeutics Market
31.1. South America Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Peptide Therapeutics Market
32.1. Brazil Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Peptide Therapeutics Market
33.1. Middle East Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Peptide Therapeutics Market
34.1. Africa Peptide Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Peptide Therapeutics Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Peptide Therapeutics Market Regulatory and Investment Landscape
36. Peptide Therapeutics Market Competitive Landscape And Company Profiles
36.1. Peptide Therapeutics Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Peptide Therapeutics Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Peptide Therapeutics Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Jhonson & Jhonson Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
37. Peptide Therapeutics Market Other Major And Innovative Companies
AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group
38. Global Peptide Therapeutics Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Peptide Therapeutics Market
40. Peptide Therapeutics Market High Potential Countries, Segments and Strategies
40.1 Peptide Therapeutics Market In 2030 - Countries Offering Most New Opportunities
40.2 Peptide Therapeutics Market In 2030 - Segments Offering Most New Opportunities
40.3 Peptide Therapeutics Market In 2030 - Growth Strategies
